IGF1 and Parkinson disease: Despite non-significant differences between serum IGF-1 levels of early drug-naïve PD patients and HC, we could reveal that decreased concentration of CSF α-synuclein and tau proteins correlate with higher serum IGF-1 quartiles in PD patients, a finding that did not replicate in HC.